4//SEC Filing
Scanlan Sean F. 4
Accession 0000950170-25-097601
CIK 0001630627other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 5:00 PM ET
Size
7.1 KB
Accession
0000950170-25-097601
Insider Transaction Report
Form 4
Scanlan Sean F.
Chief Innovation Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-18$0.72/sh+33,437$24,001→ 383,621 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-18−33,437→ 0 totalExercise: $0.72From: 2019-07-28Exp: 2025-07-28→ Common Stock (33,437 underlying)
Footnotes (3)
- [F1]Includes 325,098 restricted stock units.
- [F2]Reflects the transfer of 13,897 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.
- [F3]The stock option vested in equal annual installments over 4 years, commencing on July 28, 2015 with the last installment vesting on July 28, 2019.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001856371
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 5:00 PM ET
- Size
- 7.1 KB